Literature DB >> 7074990

Development of diltiazem, a calcium antagonist: coronary vasodilating and antihypertensive actions.

T Nagao, H Narita, M Sato, H Nakajima, A Kiyomoto.   

Abstract

We found that the coronary vasodilating action resides in novel 1,5-benzothiazepine derivatives. The calcium antagonistic property of diltiazem has been demonstrated in vascular and visceral smooth muscles as well as in cardiac ventricular muscle. Although the vasodilating action of diltiazem was the most potent in coronary and vertebral artery, it also dilates other peripheral arteries including renal artery. Antihypertensive action of diltiazem has been shown in several experimental models, such as SHR, renal hypertensive and DOCA/saline rats. Diuretic effect of diltiazem was observed in SHR. Following chronic administration of diltiazem to SHR, the increment of blood pressure was significantly lowered without changing body fluid. In addition, hypotensive action of diltiazem by i.c.v. was observed only at a very high dose. We assume that the vasodilating action of diltiazem is primarily involved in the mechanism responsible for its antihypertensive action.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074990     DOI: 10.3109/10641968209061591

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  4 in total

1.  Mechanism of action of clentiazem on human coronary artery and myocardium.

Authors:  H Narita; P H Zera; R Ginsburg
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium.

Authors:  H Narita; R Ginsburg
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Differential effects of Ca antagonists on the noradrenaline release and contraction evoked by nerve stimulation in the presence of 4-aminopyridine.

Authors:  H Kato; Y Takata
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

4.  Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.

Authors:  Y Nasa; K Ichihara; R Yoshida; Y Abiko
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.